November 5, 2024
•
5 min
read
Biostimulant testing for registration is the process of evaluating plant biostimulants to ensure compliance with regulatory frameworks in the European Union and United States. This involves proving efficacy in enhancing plant growth, nutrient uptake, and crop quality through field trials, laboratory testing, and regulatory assessments.
Biostimulants are regulated under the EU Fertilising Products Regulation (2019/1009) and various registration processes in the United States. To gain approval, manufacturers must demonstrate biostimulant efficacy by proving measurable benefits such as:
The following sections outline the biostimulant testing process to support these claims and achieve regulatory compliance.
Before submitting a biostimulant for regulatory approval, companies conduct extensive in-house testing to refine formulations and select the most promising products. Manufacturers start by searching for active ingredients with positive plant effects, testing them under controlled conditions before combining them into multi-component formulations. Once a product is formulated, laboratory screenings are conducted to determine its initial efficacy.
The most promising formulations are then tested in greenhouses then in field trials to simulate real growing conditions. Typically, trials are staged, starting in controlled environments and progressing to full-field conditions. This approach enables producers to fine-tune application methods, dosage, and formulations. Learn more on bioproduct field testing in our article: Biosolution Research To Maximize Crop Performance: An Agronomic Approach.
This step is particularly important for microbial plant biostimulant products, as soil health enhancement and microbial viability depend on precise application conditions.
During the final stage, field trials are conducted in a limited capacity to validate early findings under various environmental conditions, such as different soil types, climates, and stress factors. Advanced software solutions like Bloomeo Biosolutions help analyze data from these tests, enabling companies to determine precise conditions where the biostimulant is most effective. For example, software analytics might reveal that "this biostimulant enhances nutrient uptake in dry conditions with acidic soil and low salt concentration."
Only the most efficient products, that have a commercial potential, proceed to the regulatory testing are completed do companies proceed with regulatory testing to meet compliance standards.
Once a promising product has been identified, the next step is regulatory testing to validate at least one of the following official claims:
Each biostimulant industry trial should align with a defined regulatory framework, ensuring that data collection meets product label requirements.
Field trials play a crucial role in biostimulant testing, as they provide real-world data on product efficacy. These trials should be conducted under conditions that highlight the biostimulant's mode of action and active ingredients. Here are the key aspects of biostimulant field trials:
Field trials must be conducted in regions where the soil and climate conditions accentuate the biostimulant’s benefits. The selected crop must represent the intended use of the product, and deviations should be explained.
All trials require an untreated control group to compare the effects of the biostimulant. If the biostimulant contains nutrients, ensure that the control group receives equivalent nutrient inputs to isolate the specific effects of the biostimulant. In stress-resistance studies, the same stress conditions should apply to control plots, and a non-stressed, non-treated group should be included when appropriate.
The experimental design must align with the trial objectives and claims. For reliable statistical analysis, trials should be designed with sufficient replication—at least four replicates per treatment is recommended. Plot sizes depend on the crop type:
For field trials, plots should be homogeneous, or designs like the Latin square or split-plot can be employed.
The success of a biostimulant trial hinges on proper application techniques, including dose selection and timing. Example: A plant growth regulator trial in corn might involve foliar application at different growth stages to determine the optimal nutrient uptake effect.
What are the main parameters to test when preparing a biostimulant formulation?
To strengthen registration process applications, data from trials must be:
Here are the four steps involved in assessing the field effects of a biostimulant:
Using biologicals software, like Bloomeo Biosolutions, ensures quality control in data recording and statistical analysis.
Present individual trial results in a way that clearly differentiates control data and treated plot data. Use absolute values for control data and relative or absolute values for treated plots (e.g., efficacy percentages).
Present individual trial results in a way that clearly differentiates control data and treated plot data. Use absolute values for control data and relative or absolute values for treated plots (e.g., efficacy percentages).
When presenting results from multiple trials, tables or graphs can highlight key information, such as:
• Assessment periods and crop stages
• Number of trials and observed organs
• Treatment applications
Ensure that both mean values and measures of variation are included to support statistical significance.
Successfully registering a biostimulant requires well-structured testing that follows the regulatory guidelines in the European Union and United States. By following these five key steps, manufacturers develop and introduce new biologicals to the market.
To establish that a product is a genuine biostimulant, it must demonstrate specific effects under varying conditions, though this doesn’t guarantee it will perform consistently across all environments. Biostimulant companies must design flexible trials to suit the wide range of agronomic conditions where the product will be used. For biostimulants that improve nutrient availability, soil type and conditions may be more critical than the crop type when planning trials. As biostimulants become more advanced, trial designs must evolve to account for synergistic or emerging effects, which introduces new challenges.
At Doriane, we offer biologicals software that simplifies field trials, data collection, and analysis. Reach out today to enhance your biostimulant certification trials and navigate the regulatory framework with confidence.
Several factors can be taken into account, like environmics, genetics, agricultural practices and inputs. Then we deal with multi-factorial testing, also called "system trials", and this can be managed in Bloomeo. The agronomy testing software supports the research department with standardized traits and automation, thus saving time and resources. In addition, data analysis in dashboards support decision-making.
Webinar Replay
Next webinar
December 5, 2024
Easy mobility for Product Developers and Managers!
Tristan Duminil
Head of Agronomy
November 5, 2024
•
5 min
read
Biostimulant testing for registration is the process of evaluating plant biostimulants to ensure compliance with regulatory frameworks in the European Union and United States. This involves proving efficacy in enhancing plant growth, nutrient uptake, and crop quality through field trials, laboratory testing, and regulatory assessments.
Biostimulants are regulated under the EU Fertilising Products Regulation (2019/1009) and various registration processes in the United States. To gain approval, manufacturers must demonstrate biostimulant efficacy by proving measurable benefits such as:
The following sections outline the biostimulant testing process to support these claims and achieve regulatory compliance.
Before submitting a biostimulant for regulatory approval, companies conduct extensive in-house testing to refine formulations and select the most promising products. Manufacturers start by searching for active ingredients with positive plant effects, testing them under controlled conditions before combining them into multi-component formulations. Once a product is formulated, laboratory screenings are conducted to determine its initial efficacy.
The most promising formulations are then tested in greenhouses then in field trials to simulate real growing conditions. Typically, trials are staged, starting in controlled environments and progressing to full-field conditions. This approach enables producers to fine-tune application methods, dosage, and formulations. Learn more on bioproduct field testing in our article: Biosolution Research To Maximize Crop Performance: An Agronomic Approach.
This step is particularly important for microbial plant biostimulant products, as soil health enhancement and microbial viability depend on precise application conditions.
During the final stage, field trials are conducted in a limited capacity to validate early findings under various environmental conditions, such as different soil types, climates, and stress factors. Advanced software solutions like Bloomeo Biosolutions help analyze data from these tests, enabling companies to determine precise conditions where the biostimulant is most effective. For example, software analytics might reveal that "this biostimulant enhances nutrient uptake in dry conditions with acidic soil and low salt concentration."
Only the most efficient products, that have a commercial potential, proceed to the regulatory testing are completed do companies proceed with regulatory testing to meet compliance standards.
Once a promising product has been identified, the next step is regulatory testing to validate at least one of the following official claims:
Each biostimulant industry trial should align with a defined regulatory framework, ensuring that data collection meets product label requirements.
Field trials play a crucial role in biostimulant testing, as they provide real-world data on product efficacy. These trials should be conducted under conditions that highlight the biostimulant's mode of action and active ingredients. Here are the key aspects of biostimulant field trials:
Field trials must be conducted in regions where the soil and climate conditions accentuate the biostimulant’s benefits. The selected crop must represent the intended use of the product, and deviations should be explained.
All trials require an untreated control group to compare the effects of the biostimulant. If the biostimulant contains nutrients, ensure that the control group receives equivalent nutrient inputs to isolate the specific effects of the biostimulant. In stress-resistance studies, the same stress conditions should apply to control plots, and a non-stressed, non-treated group should be included when appropriate.
The experimental design must align with the trial objectives and claims. For reliable statistical analysis, trials should be designed with sufficient replication—at least four replicates per treatment is recommended. Plot sizes depend on the crop type:
For field trials, plots should be homogeneous, or designs like the Latin square or split-plot can be employed.
The success of a biostimulant trial hinges on proper application techniques, including dose selection and timing. Example: A plant growth regulator trial in corn might involve foliar application at different growth stages to determine the optimal nutrient uptake effect.
What are the main parameters to test when preparing a biostimulant formulation?
To strengthen registration process applications, data from trials must be:
Here are the four steps involved in assessing the field effects of a biostimulant:
Using biologicals software, like Bloomeo Biosolutions, ensures quality control in data recording and statistical analysis.
Present individual trial results in a way that clearly differentiates control data and treated plot data. Use absolute values for control data and relative or absolute values for treated plots (e.g., efficacy percentages).
Present individual trial results in a way that clearly differentiates control data and treated plot data. Use absolute values for control data and relative or absolute values for treated plots (e.g., efficacy percentages).
When presenting results from multiple trials, tables or graphs can highlight key information, such as:
• Assessment periods and crop stages
• Number of trials and observed organs
• Treatment applications
Ensure that both mean values and measures of variation are included to support statistical significance.
Successfully registering a biostimulant requires well-structured testing that follows the regulatory guidelines in the European Union and United States. By following these five key steps, manufacturers develop and introduce new biologicals to the market.
To establish that a product is a genuine biostimulant, it must demonstrate specific effects under varying conditions, though this doesn’t guarantee it will perform consistently across all environments. Biostimulant companies must design flexible trials to suit the wide range of agronomic conditions where the product will be used. For biostimulants that improve nutrient availability, soil type and conditions may be more critical than the crop type when planning trials. As biostimulants become more advanced, trial designs must evolve to account for synergistic or emerging effects, which introduces new challenges.
At Doriane, we offer biologicals software that simplifies field trials, data collection, and analysis. Reach out today to enhance your biostimulant certification trials and navigate the regulatory framework with confidence.
Several factors can be taken into account, like environmics, genetics, agricultural practices and inputs. Then we deal with multi-factorial testing, also called "system trials", and this can be managed in Bloomeo. The agronomy testing software supports the research department with standardized traits and automation, thus saving time and resources. In addition, data analysis in dashboards support decision-making.